Plastic Surgery

The Invisible Bottleneck of Breast Reconstruction in the SUS

April 25, 2026
By Fernando Amato

Breast reconstruction in the SUS (Brazil's public health system) exposes a significant contradiction in oncological care in Brazil. For years, the country has recognized that this surgery is part of the comprehensive care for women undergoing mastectomy. Even so, actual access remains unequal, slow, and frequently interrupted by organizational barriers that are not very visible in public debate.

When it comes to breast cancer, attention usually focuses on diagnosis, oncological surgery, chemotherapy, and radiotherapy. Reconstruction, however, is often pushed back, as if it were a secondary stage.

This scenario is even more pressing because breast cancer remains one of the main challenges in women's health. For the 2026 to 2028 triennium, INCA estimates 78,610 new cases per year in Brazil. This shows that the demand for breast reconstruction is not occasional. It is a continuous, predictable, and structural need.

Breast reconstruction in the SUS is not an aesthetic detail

Treating breast reconstruction as something accessory is a mistake. It is not just about appearance. It is related to physical rehabilitation, body image, self-esteem, and quality of life after breast cancer treatment.

Fiocruz itself highlights that care should be interdisciplinary and aimed not only at cure, but also at quality of life. This includes informing the patient about her right to reconstruction.

In practice, a woman's journey does not end with mastectomy. When reconstruction is indefinitely postponed, the system conveys the message that survival is enough. But surviving is not the same as rehabilitating. A mature oncological policy needs to contemplate both dimensions.

The right exists, but access continues to fail

Brazil has made progress at the legal level. Law No. 12,802/2013 determined that, when clinical conditions allow, breast reconstruction should be performed at the same surgical time as mastectomy. If this is not possible, the subsequent procedure must also be guaranteed.

In 2018, Law No. 13,770 reinforced this right in cases of mutilation resulting from cancer treatment. In 2025, Law No. 15,171 expanded the right to reconstructive breast surgery for cases of total or partial mutilation, regardless of the cause.

The problem is that the law, by itself, does not create trained teams, surgical rooms, regulated flows, or integration between services. This is the core of the invisible bottleneck. The challenge is not just in recognizing the right, but in the system's capacity to deliver this care at scale.

The extent of the care delay

Available data shows a persistent gap between need and supply. In 2023, the Ministry of Health reported that more than 20,000 women were awaiting breast reconstruction in the public network and announced an investment of over R$100 million to expand access.

READ Breast Surgery Scars: Periareolar, Vertical, "J" , "L" and Inverted "T"

Even so, recent signs indicate that the structural deficit remains. In 2024, a report echoed by Oncoguia pointed out that only 25% to 30% of women undergoing mastectomy are able to undergo reconstruction through the SUS. The same material cites about 10,000 breast reconstructions performed in 2021, compared to approximately 23,000 annual mastectomies.

In April 2026, the Sociedade Brasileira de Mastologia (Brazilian Society of Mastology) once again warned that only 20% of SUS patients have access to reconstruction after mastectomy. Percentages vary depending on the analyzed database, but the direction is the same: under-access remains significant.

Furthermore, a journalistic survey with Ministry of Health data showed, in March 2025, that reconstructive surgery was among the procedures with the longest average waiting time in the SUS, potentially approaching two years in some scenarios. Even when the waiting list does not formally appear as “breast reconstruction,” this environment of delay helps explain why so many women face a second battle after oncological treatment.

Why the line moves slowly

The delay cannot be explained solely by the lack of surgical vacancies. This is an important factor, but not the only one.

Many patients do not even enter a clear reconstruction flow at the time of oncological planning. When mastology, clinical oncology, radiotherapy, plastic surgery, physiotherapy, and regulation work in a fragmented way, reconstruction becomes treated as a later stage, without a deadline, without a well-defined priority, and without coordination along the journey.

There is also a strong concentration of specialized teams in few centers. This increases regional inequality, increases the need for displacement, and reduces predictability for the patient.

Another problem is the competition for space in the operating room. When there is no protected schedule, dedicated operating block, or specific goals for breast reconstruction, cases tend to be repeatedly postponed.

Furthermore, patients are not all the same from a technical point of view. Some can have immediate reconstruction. Others need staged reconstruction. There are also more complex cases, requiring expanders, flaps, or lipofilling. Without organization by degree of complexity, the system mixes different profiles in the same queue and loses efficiency.

Equity is not offering the same to everyone

Talking about equity is more than saying that the law applies throughout the country. Equity means recognizing that access conditions are unequal from the start.

READ Do you know what symmastia is? Discover how it can arise and be treated

A woman treated in a center with structured mastology, reconstructive plastic surgery, and integrated radiotherapy has a more concrete chance of reconstruction in adequate time. Another woman, in a region with lower care density, may finish oncological treatment without even entering a consistent rehabilitation flow.

Therefore, expanding access does not depend only on opening vacancies. It requires care models capable of reducing variability between territories, standardizing criteria, organizing regional references, and monitoring indicators across the entire care continuum.

Scalable care models: where the SUS can advance

Breast reconstruction in the SUS needs to move away from an improvised logic and enter a logic of care lines with installed capacity.

A first step is to incorporate reconstruction into oncological planning from the outset. Whenever clinically viable, the discussion about immediate reconstruction should take place within the same therapeutic decision-making flow. This reduces lost opportunities and avoids creating a second waiting list.

Another path is to regionalize more intelligently. Not every hospital needs to perform all types of reconstruction, but the network can define reference centers according to the degree of complexity, with clear referral and return protocols.

It is also important to work with protected surgical schedules and specific care goals. When breast reconstruction is only included in the general set of reconstructive surgeries, it tends to lose operational priority. Monitored production, transparent waiting lists, and public indicators help provide predictability.

Multiprofessional training and integration are also crucial. Breast reconstruction does not depend only on the plastic surgeon. It involves mastology, nursing, physiotherapy, psychology, anesthesia, regulation, and primary care.

Finally, it is worth considering hybrid models, with qualified medical campaigns and social projects articulated with the public network. Initiatives like Mama Minha and IRMAMAS draw attention because they do not just offer surgery. They show how screening, integrated teams, institutional partnership, and continuity of care can generate real impact.

From surgery to comprehensive care

Breast reconstruction is not limited to the operative act. Functional rehabilitation, complication prevention, psychological support, guidance, and follow-up are also part of care.

This point is crucial because, when care is organized only around the tumor, the woman may leave treated from an oncological perspective, but still underserved in her global rehabilitation. Breast reconstruction needs to be understood as part of the continuum of care, not as an optional supplement.

READ Mammaplasty with mesh: what it is and when it may be indicated

What this bottleneck reveals

The wait for breast reconstruction reveals a greater challenge for the SUS. It is not enough to guarantee access to life-saving treatment. It is also necessary to guarantee access to rehabilitative care.

Mature systems do not measure success only by tumor removal or protocol completion. They also measure their ability to restore function, autonomy, and dignity.

If breast reconstruction continues to be pushed to the end of the line, it will remain invisible to management and painfully concrete for the patient. The challenge, therefore, is not just to increase numbers. It is to redesign flows, reduce inequalities, agree on responsibilities, and recognize that, in many cases, rebuilding the breast also means rebuilding life.

FAQ

Is breast reconstruction mandatory for every patient undergoing mastectomy?

No. Breast reconstruction is a right, not an obligation. The decision depends on clinical factors, oncological treatment, patient preferences, and the assessment of the care team.

Does reconstruction need to be performed at the same time as mastectomy?

Whenever adequate clinical and oncological conditions exist, legislation provides for reconstruction at the same surgical time. When this is not possible, the procedure can be scheduled for later, without loss of the right.

Why are so many women still waiting for reconstruction in the SUS?

The delay usually results from a combination of several factors: lack of specialized teams, poor integration between services, limited operating room availability, regional inequality, and inefficient regulatory flows. In many places, the problem is more organizational than legal.

Is breast reconstruction just an aesthetic issue?

No. Body appearance is part of the discussion, but it does not summarize the problem. Reconstruction is also linked to physical rehabilitation, body image, self-esteem, and quality of life after cancer treatment.

Do scalable models mean mass surgeries without individualization?

No. Scalability, in healthcare, means organizing the network to serve more people with clear criteria, safety, and continuity of care. This includes reference centers, well-defined protocols, and adequate follow-up.

Can social projects replace public policy?

No. They can alleviate waiting lists, test organizational models, and produce replicable solutions. But the primary responsibility remains with the public system.

Can every patient undergo the same type of reconstruction?

No. There are different techniques, such as immediate reconstruction, staged reconstruction, with expanders, implants, flaps, or fat grafting. The choice should be individualized according to the clinical condition, the treatment received, and the need for radiotherapy.

Recommended video: Reconstrução Mamária: O Projeto Transformador “Mama Minha” — https://www.youtube.com/watch?v=M5bxjtTGbU4